XYL
54
2
PG
53
-8
URBN
82
2
DNB
78
-4
PSA
53
-7
PNW
63
-3
IVZ
52
-3
TXN
43
-3
MRK
37
4
GOOG
63
-2
CHD
47
-6
ABT
57
-3
AVGO
32
2
LB
45
11
K
51
-2
XRX
41
-5
DUK
54
-3
EXR
57
-5
A
41
-2
FOXA
45
-7
XYL
54
2
PG
53
-8
URBN
82
2
DNB
78
-4
PSA
53
-7
PNW
63
-3
IVZ
52
-3
TXN
43
-3
MRK
37
4
GOOG
63
-2
CHD
47
-6
ABT
57
-3
AVGO
32
2
LB
45
11
K
51
-2
XRX
41
-5
DUK
54
-3
EXR
57
-5
A
41
-2
FOXA
45
-7
Financhill
Back

NovoCure Quote, Financials, Valuation and Earnings

32,481% Growth: Invest in the Smartphone Revolution @ $0.26/Share

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
77

NVCR
NovoCure

Last Price:
28.82
Seasonality Move:
2.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

NovoCure Price Quote

$28.82
-1.69 (-5.54%)
(Updated: December 4, 2024 at 2:00 PM ET)

NovoCure Key Stats

Buy
77
NovoCure (NVCR) is a Buy
Day range:
$29.05 - $32.60
52-week range:
$11.66 - $32.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.68
P/B ratio:
9.15%
Volume:
3.9M
Avg. volume:
1.4M
1-year change:
144.08%
Market cap:
$3.3B
Revenue:
$509.3M
EPS:
$-1.4

How Much Does NovoCure Make?

  • How Much Are NovoCure's Sales Annually?
    NVCR Revenues are $509.3M
  • How Much Profit Does NovoCure's Make A Year?
    NVCR net income is -$207M

Is NovoCure Growing As A Company?

  • What Is NovoCure's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.22%
  • What Is NovoCure's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

NovoCure Stock Price Performance

  • Did NovoCure Stock Go Up Last Month?
    NovoCure share price went up by 88.57% last month
  • Did NVCR's Share Price Rise Over The Last Year?
    NVCR share price rose by 144.08% over the past 1 year

What Is NovoCure 52-Week High & Low?

  • What Is NovoCure’s 52-Week High Share Price?
    NovoCure has traded as high as $32.60 over the past 52 weeks
  • What Is NovoCure’s 52-Week Low Share Price?
    NovoCure has traded as low as $11.66 over the past 52 weeks

NovoCure Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy NovoCure?

  • How Much Debt Does NovoCure Have?
    Total long term debt quarterly is $654.5M
  • How Much Cash Does NovoCure Have?
    Cash and short term investments quarterly total is $959.9M
  • What Is NovoCure’s Book Value Per Share?
    Book value per share is 3.34

Is NovoCure Cash Flow Positive?

  • What Is NVCR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$37.5M
  • What Is NovoCure’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $89.5M
  • What Is NovoCure’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$19.5M

NovoCure Return On Invested Capital

  • Is Management Doing A Good Job?
    NVCR return on invested capital is -15.43%
  • What Is NovoCure Return On Assets?
    ROA measures how assets are converting to revenues and is -12.81%
  • What Is NVCR Return On Equity?
    ROE is a measure of profitability and is -40.75%

NovoCure Earnings Date & Stock Price

  • What Is NovoCure's Stock Price Today?
    A single share of NVCR can be purchased today for 30.51
  • What Is NovoCure’s Stock Symbol?
    NovoCure trades on the nasdaq under the ticker symbol: NVCR
  • When Is NovoCure’s Next Earnings Date?
    The next quarterly earnings date for NovoCure is scheduled on February 21, 2025
  • When Is NVCR's next ex-dividend date?
    NovoCure's next ex-dividend date is December 4, 2024
  • How To Buy NovoCure Stock?
    You can buy NovoCure shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

NovoCure Competitors

  • Who Are NovoCure's Competitors?
    Below is a list of companies who compete with NovoCure or are related in some way:
    • Abbott Laboratories (ABT)
    • Perspective Therapeutics Inc (CATX)
    • Retractable Technologies Inc (RVP)
    • Catheter Precision Inc (VTAK)
    • Xtant Medical Holdings Inc (XTNT)

NovoCure Dividend Yield

  • What Is NVCR Dividend Yield?
    NovoCure’s dividend yield currently is 0%
  • What Is NovoCure’s Payout Ratio?
    NovoCure’s payout ratio is 0%
  • When Did NovoCure Last Pay A Dividend?
    The latest dividend pay date is December 4, 2024
  • What Is NovoCure’s Dividend Per Share?
    NovoCure pays a dividend of $0.00 per share

NovoCure Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 16.22%
Revenue: 21.81% 7.74%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 31.57
Upside from Last Price: 3.48%

Major Shareholders

  • How many NVCR shares are owned by institutional investors?
    205.3M NVCR shares are owned by institutional investors
  • How many NVCR shares are owned by insiders?
    9M NVCR shares are owned by insiders